International Journal of Drug Policy
Volume 21, Issue 4 , Pages 265-270 , July 2010

Illicit drugs policy through the lens of regulation

  • Alison Ritter

      Affiliations

    • Drug Policy Modelling Program, UNSW, Australia
    • Regulatory Institutions Network, The ANU, Australia
    • Corresponding Author InformationCorrespondence address: Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of NSW, Sydney, NSW, 2052, Australia. Tel.: +61 2 9385 0236; fax: +61 2 9385 0222.

Received 23 May 2009 ,Revised 14 September 2009 ,Accepted 8 November 2009.

References 

  1. Ayres I, Braithwaite J. Responsive regulation: Transcending the deregulation debate. New York: Oxford University Press; 1992;
  2. Baldacchino A, Hussein Rassool G. The self-help movement in the addiction field-revisited. Journal of Addictions Nursing. 2006;17:47–52
  3. Bewley-Taylor D. Challenging the UN drug control conventions: Problems and possibilities. International Journal of Drug Policy. 2003;14:171–179
  4. Bewley-Taylor D. Emerging policy contradictions between the United Nations drug control system, and the core values of the United Nations. International Journal of Drug Policy. 2005;16:423–431
  5. Braithwaite J, Drahos P. Global business regulation. Cambridge: Cambridge University Press; 2000;
  6. Braithwaite J, Healy J, Dwan K. The governance of health, safety and quality: A discussion paper. Canberra: Australian Council for Safety and Quality in Health Care, Commonwealth of Australia; 2005;
  7. Bryant J, Saxton M, Madden A, Bath N, Robinson S. Consumer participation in the planning and delivery of drug treatment services: The current arrangements. Drug and Alcohol Review. 2008;27(2):130–137
  8. Bryant J, Saxton M, Madden A, Bath N, Robinson S. Consumers’ and providers’ perspectives about consumer participation in drug treatment services: Is there support to do more? What are the obstacles?. Drug and Alcohol Review. 2008;27(2):138–144
  9. Burris S. Governance, microgovernance and health. Temple Law Review. 2004;77:335–362
  10. Burris S. From security to health. In:  Wood J,  DuPont B editor. Democracy, society and the governance of security. Cambridge: Cambridge University Press; 2006;
  11. Camilleri AM, Caldicott D. Underground pill testing, down under. Forensic Science International. 2005;151:53–58
  12. Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Working with heroin sniffers: Clinical issues in preventing drug injection. Journal of Substance Abuse Treatment. 1990;7(1):1–10
  13. Caulkins J, Johnson B, Taylor A, Taylor L. What drug dealers tell us about their costs of doing business. Journal of Drug Issues. 1999;29:323–340
  14. Cherney A, O’Reilly J, Grabosky P. The governance of illicit synthetic drugs: National drug law enforcement research fund. Commonwealth of Australia; 2005;
  15. Cherney A, O’Reilly J, Grabosky P. The multilateralization of policing: The case of synthetic drug control. Police Practice and Research. 2006;7(3):177–194
  16. Cherney A, O’Reilly J, Grabosky P. Networks and meta-regulation: Strategies aimed at governing illicit synthetic drugs. Policing and Society. 2006;16(4):370–385
  17. Coomber R. Editorial: Drug use and drug market intersections. Addiction Research & Theory. 2004;12(6):501–505
  18. Csete J, Wolfe D. Dangerously out of step: The International Narcotics Control Board and HIV/AIDS. Global AIDSLink. 2007;105:15–18
  19. Denhardt RB, Denhardt JV. The new public service: Serving rather than steering. Public Administration Review. 2000;60(6):549–559
  20. Derzon JH, Lipsey MW. A meta-analysis of the effectiveness of mass-communication for changing substance-use knowledge, attitudes, and behavior. In:  Crano WD,  Burgoon M editor. Mass media and drug prevention: Classic and contemporary theories and research. London: Lawrence Erlbaum Associates; 2002;
  21. Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection-results of a randomized trial prevention program. British Journal of Addiction. 1992;87(3):493–498
  22. Dolan K, Clement N, Rouen D, Rees V, Shearer J, Wodak A. Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?. Drug and Alcohol Review. 2004;23(3):281–286
  23. Dorn N, Murji K, South N. Traffickers: Drug markets and law enforcement. London: Routledge; 1992;
  24. Duffield M. Global governance and the new wars. London: Zed Books Ltd.; 2001;
  25. DuPont B, Grabosky P, Shearing C. The governance of security in weak and failing states. Criminal Justice. 2003;3(4):331–349
  26. Faggiano F, Vigna-Taglianti F, Versino E, Zambon A, Borraccino A, Lemma P. Cochrane Database of Systematic Reviews. 2005;
  27. Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: A randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes. 2003;33(2):199–205
  28. Friedman SR, Curtis R, Jose B, Flom PL, Neaigus A, Des Jarlais DC. The message not heard: Myth and reality in discussions about syringe exchange. AIDS. 1999;13(6):738–739
  29. Goldsmith S, Eggers WD. Governing by network: The new shape of the public sector. Washington, DC: The Brookings Institution; 2004;
  30. Grabosky P. Green markets: Environmental regulation by the private sector. Law & Policy. 1994;16(4):419–448
  31. Grabosky, P. (1997). Discussion paper: Inside the pyramid.
  32. Grabosky P, Braithwaite J. Of manners gentle: Enforcement strategies of Australian business regulatory agencies. Melbourne: Oxford University Press; 1986;
  33. In:  Grabosky P,  Braithwaite J editor. Business regulation and Australia's future. 1993;
  34. Green T, Heimer R, Grau L. Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of six overdose training and naloxone distribution programs in the United States. Addiction. 2008;103:979–989
  35. Gunningham N, Grabosky P. Smart regulation. Oxford: Oxford University Press; 1998;
  36. Hunt, N., Derricott, J., Preston, A., & Stillwell, G. (2001). Preventing initiation into injecting. www.exchangesupplies.org/campaignmaterials Accessed 22.09.05.
  37. Hunt N, Griffiths P, Southwell R, Stillwell G, Strang J. Preventing and curtailing injecting drug use: A review of opportunities for developing and delivering ‘route transition interventions’. Drug and Alcohol Review. 1999;18(4):441–451
  38. Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs: Education, Prevention and Policy. 1998;5(2):185–194
  39. Kim D, Irwin K, Khoshnood K. Expanded access to naloxone: Options for critical response to the epidemic of opioid overdose mortality. American Journal of Public Health. 2009;99:402–407
  40. Kleber H. Our current approach to drug abuse—Progress, problems, proposals. The New England Journal of Medicine. 1994;330:361–365
  41. Kriener H, Billeth R, Gollner C, Lachout S, Neubauer P, Schmid R. An inventory of on-site pill-testing interventions in the EU. Vienna, Austria: European Monitoring Centre for Drugs and Drug Addiction; 2001;
  42. Kriener, H., & Schmid, R. (2005). Check your pills. Check your life. ChEck iT! High quality on-site testing of illicit substances. Information, counselling and safer use measures at raves in Austria. http://www.drugtext.org/library/articles/kriener.htm Accessed 14.09.05.
  43. Lenton S, Hargreaves K. Should we trial the provision of naloxone to heroin users for peer administration to prevent fatal overdose?. Medical Journal Australia. 2000;173:260–263
  44. MacCoun RJ, Reuter P. Drug war heresies: Learning from other vices, times and places. New York: Cambridge University Press; 2001;
  45. May T, Hough M. Drug markets and distribution systems. Addiction Research & Theory. 2004;12(6):549–563
  46. Mazerolle L, Ransley J. Third party policing. Cambridge: Cambridge University Press; 2005;
  47. Mazerolle L, Soole D, Rombouts S. Street-level drug law enforcement: A meta-analytic review. Journal of Experimental Criminology. 2006;2(4):409–435
  48. Mazerolle L, Soole D, Rombouts S. Drug law enforcement: A review of the evaluation literature. Police Quarterly. 2007;10(2):115–153
  49. Munro J, de Wever J. Culture clash: Alcohol marketing and public health aspirations. Drug and Alcohol Review. 2008;27:204–211
  50. Nadelmann E. Drug prohibition in the United States: Costs, consequences, and alternatives. Science. 1989;245(4921):939–947
  51. Natarajan M, Belanger M. Varieties of drug trafficking organisations: A typology of cases prosecuted in New York City. Journal of Drug Issues. 1998;28(4):1005–1026
  52. Natarajan M, Hough M. Illegal drug markets: From research to prevention policy. New York: Criminal Justice Press; 2000;
  53. Navarrete-Frias C, Thoumi FE. Illegal drugs, human rights of peasants and indigenous communities: The case of Colombia. United Nations Educational, Scientific and Cultural Organization; 2005;
  54. Osborne D, Gaebler T. Reinventing government: How the entrepreneurial spirit is transforming the public sector. Reading, MA: Addison-Wesley; 1992;
  55. Palmgreen P, Donohew L. Effective mass media strategies of drug abuse prevention campaigns. In:  Sloboda Z,  Bukoski WJ editor. Handbook of drug abuse prevention: Theory, science and practice. New York: Kluwer Academic/Plenum Publishers; 2003;
  56. Preble E, Casey J. Taking care of business. International Journal of Addictions. 1996;4:1–24
  57. In:  Reuter P,  Trautmann F editor. A Report on Global Illicit Drugs Markets 1998–2007. European Commission; 2009;
  58. Ritter A. Studying drug markets: Disciplinary contributions. International Journal of Drug Policy. 2006;17:453–463
  59. Room R. The rhetoric of international drug control. Substance Use and Misuse. 1999;34(12):1687–1707
  60. Rose N, Miller P. Political power beyond the State: Problematics of government. British Journal of Sociology. 1992;43(2):173–205
  61. Saunders B, Yap E. Do our guardians need guarding? An examination of the Australian system of self-regulation of alcohol advertising?. Drug and Alcohol Review. 1991;10:15–27
  62. Shearing C. Reflections on the refusal to acknowledge private governments. In:  Wood J,  DuPont B editor. Democracy, society and the governance of security. Cambridge: Cambridge University Press; 2006;p. 11–32
  63. Skager R. Replacing ineffective early alcohol/drug education in the United States with age-appropriate adolescent programmes and assistance to problematic users. Drug and Alcohol Review. 2007;26(6):577–584
  64. Small D, Drucker E. Closed to reason: Time for accountability for the International Narcotic Control Board. Harm Reduction Journal. 2007;4:13
  65. South N. Managing work, hedonism and the borderline between the legal and illegal markets: Two case studies of recreational drug users. Addiction Research & Theory. 2004;12(6):525–538
  66. Spruit IP. Monitoring synthetic drug markets, trends, and public health. Substance Use and Misuse. 2001;36(1&2):23–47
  67. Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L, et al. Overdose training and provision of take-home naloxone to opiate users: Prospective cohort study of immediate and lasting impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008;103:1648–1657
  68. Tobin K, Sherman S, Beilenson P, Welsh C, Latkin C. Evaluation of the Staying Alive programme: Training injection drug users to properly administer naloxone and save lives. International Journal of Drug Policy. 2009;20:
  69. UNGASS Action Plan on International Cooperation on the Eradication of Illicit Drug Crops on the Alternative Development. http://www.unodc.org/unodc/en/alternative-development/ungass-action-plan-on-eradication-and-alternative-development.html Accessed 08.01.09.
  70. United Nations Office on Drugs and Crime (UNODC). (2007). World Drug Report 2007. Vienna.
  71. van de Wijngaart GF, Braam RV, de Bruin DE, Fris M, Maalste NJM, Verbraeck HT. Ecstasy use at large-scale dance events in the Netherlands. Journal of Drug Issues. 1999;29(3):679–702
  72. Winstock AR, Wolff K, Ramsey J. Ecstasy pill testing: Harm minimization gone too far?. Addiction. 2001;96:1139–1148
  73. Wodak A, Reinarman C, Cohen P. Cannabis control: Costs outweight the benefits. British Medical Journal. 2002;324:105–106
  74. In:  Wood J,  Dupont B editor. Democracy, society and the governance of security. Cambridge: Cambridge University Press; 2006;
  75. Wood J, Shearing C. Imagining security. Devon: Willan Publishing; 2007;

PII: S0955-3959(09)00153-4

doi: 10.1016/j.drugpo.2009.11.002

International Journal of Drug Policy
Volume 21, Issue 4 , Pages 265-270 , July 2010

Article Tools